| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/17/2013 | US20130017993 Glycoside derivatives and uses thereof |
| 01/17/2013 | US20130017565 Methods and products related to low molecular weight heparin |
| 01/17/2013 | US20130017277 Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
| 01/17/2013 | US20130017262 Immediate/delayed drug delivery |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017250 Methods For High Density Lipoprotein Cholesterol Regulation |
| 01/17/2013 | US20130017227 Wound healing compositions and associated methods |
| 01/17/2013 | US20130017208 Anti-IL-6 Antibodies, Compositions, Methods and Uses |
| 01/17/2013 | US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 01/17/2013 | US20130017197 Stabilized antibody preparations and uses thereof |
| 01/17/2013 | US20130017192 Diagnosis and Treatment of Autoantibody-Mediated Heart Disease |
| 01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
| 01/17/2013 | US20130017183 Compositions containing non-polar compounds |
| 01/17/2013 | US20130017180 Platelet rich plasma formulations |
| 01/17/2013 | US20130017176 Compositions comprising cardiac stem cells overexpressing specific micrornas and methods of their use in repairing damaged myocardium |
| 01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/17/2013 | US20130017166 Protein-Poly(2-oxazoline) Conjugates for Enhanced Cellular Delivery and Transport Across Biological Barriers |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2844150A1 Methods for treating inflammation and hypertension with gamma-ketoaldehyde skavengers |
| 01/17/2013 | CA2843777A1 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | CA2843773A1 Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | CA2841897A1 Novel compound having parp inhibitory activity |
| 01/17/2013 | CA2841548A1 Sumoylation of serca2a and cardiovascular disease |
| 01/17/2013 | CA2841451A1 Ischemic disease therapeutic agent |
| 01/17/2013 | CA2841117A1 Method of treating atherosclerosis in high triglyceride subjects |
| 01/16/2013 | EP2546269A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 01/16/2013 | EP2546266A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 01/16/2013 | EP2546253A1 Substituted dihydropyrazolones for the treatment of cardiovascular and hematological diseases |
| 01/16/2013 | EP2546239A1 6-amino isoquinolins compounds and methods for making the same |
| 01/16/2013 | EP2546238A1 6-amino isoquinolins compounds and methods for making the same |
| 01/16/2013 | EP2546237A1 7-amino isoquinolins compounds and methods for making the same |
| 01/16/2013 | EP2546232A1 Diphenyl Substituted Alkanes |
| 01/16/2013 | EP2545941A1 Method for proliferating cardiomyocytes using micro-rna |
| 01/16/2013 | EP2545926A1 Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 01/16/2013 | EP2545917A1 Novel ep4 agonist |
| 01/16/2013 | EP2545080A2 Npp1 fusion proteins |
| 01/16/2013 | EP2545065A2 Water-soluble phytosterol derivatives for reducing cholesterol and preparation thereof |
| 01/16/2013 | EP2545037A1 Inhibitors of protein kinases |
| 01/16/2013 | EP2545025A1 Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | EP2544703A2 Methods of treating vascular inflammatory disorders |
| 01/16/2013 | EP2544681A1 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for administration shortly after amiodarone discontinuation |
| 01/16/2013 | EP2544542A1 Analgesic compounds, compositions, and uses thereof |
| 01/16/2013 | CN102884065A Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 01/16/2013 | CN102884063A Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators |
| 01/16/2013 | CN102884056A Ketobenzofuran derivatives, method for synthesising same, and intermediates |
| 01/16/2013 | CN102884053A Cyclopropanecarboxylic acid derivative |
| 01/16/2013 | CN102884052A Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/16/2013 | CN102884049A Heterocyclic amides as ROCK inhibitors |
| 01/16/2013 | CN102884047A 2-pyridone compounds |
| 01/16/2013 | CN102884037A Synthesis of alpha-tocopherolquinone derivatives, and methods of using the same |
| 01/16/2013 | CN102883736A Peptides for promoting angiogenesis and a use thereof |
| 01/16/2013 | CN102883733A AGE production inhibitor |
| 01/16/2013 | CN102883730A Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
| 01/16/2013 | CN102883722A Treatment for pulmonary hypertension |
| 01/16/2013 | CN102876696A Preparation method and application of tissue in situ high-expression ILK (integrin linked kinase) protein carrier |
| 01/16/2013 | CN102876553A Preparation method of high-quality mung bean liquor |
| 01/16/2013 | CN102875677A Humanized anti-egfl7 antibodies and methods using same |
| 01/16/2013 | CN102875676A Human anti-human VEGF monoclonal antibody molecule and application thereof |
| 01/16/2013 | CN102875644A GRPAK/tetrahydroglyoxaline/RGD ternary conjugate as well as preparation method and application thereof |
| 01/16/2013 | CN102875620A New derivatives of myricetin and application of derivatives to medicine preparation |
| 01/16/2013 | CN102875523A 丹参丹酚酸f衍生物及药用用途 Salvia Sal f derivatives and medicinal uses |
| 01/16/2013 | CN102875516A Isochromanone derivatives with beta-receptor blocking activity, and preparation method and application thereof |
| 01/16/2013 | CN102875513A Microcrystal catechin and preparation method thereof |
| 01/16/2013 | CN102875480A Quinazolinone vasoinhibitors, and preparation method and medical application thereof |
| 01/16/2013 | CN102875477A Phenyl piperazinepyridazinone and preparation method as well as application thereof |
| 01/16/2013 | CN102875441A Plexxikon inc |
| 01/16/2013 | CN102875430A Modafinil polymorphic forms |
| 01/16/2013 | CN102872464A Novel choroidal neovascularization gene therapeutic medicine and use thereof |
| 01/16/2013 | CN102872455A Medicament for preventing in-stent restenosis after coronary stent implantation and preparation method |
| 01/16/2013 | CN102872431A Capsules for treating deficiency-cold in spleen and stomach |
| 01/16/2013 | CN102872421A Traditional Chinese medicine blood stasis dissipating mixture for treating cranial injury sequelae |
| 01/16/2013 | CN102872382A Achyranthes bidentata tablet for calming liver and relieveing dizziness |
| 01/16/2013 | CN102872360A Chinese herba preparation for treating cerebral arteriosclerosis |
| 01/16/2013 | CN102872353A Medicament for treating hypertension dizzy |
| 01/16/2013 | CN102872335A Externally used Chinese medicine preparation for curing diabetic foot and preparation method thereof |
| 01/16/2013 | CN102872322A Tortoise plastron tablets for nourishing yin |
| 01/16/2013 | CN102872308A Snake gourd fruit tablets for promoting circulation of qi and removing stasis |
| 01/16/2013 | CN102872306A Compound selenium Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 01/16/2013 | CN102872297A Tablets for tonifying kidney and replenishing essence |
| 01/16/2013 | CN102872281A Medicine tea for treating apoplexy |
| 01/16/2013 | CN102872279A Tablets for clearing away lower energizer and dampness-heat |
| 01/16/2013 | CN102872268A Borax powder for treating haemorrhoids |
| 01/16/2013 | CN102872258A Externally applied drug for curing thromboangiitis obliterans |
| 01/16/2013 | CN102872254A Granules for activating blood and removing stasis |
| 01/16/2013 | CN102872237A Skunk bugbane spleen-qi raising tablet |
| 01/16/2013 | CN102872236A Extraction process of flavedo flavone |
| 01/16/2013 | CN102872227A Gelan Xinning soft capsule for treating coronary disease and angina and preparation method thereof |
| 01/16/2013 | CN102872223A Health protection medicine for enriching blood and prolonging life |
| 01/16/2013 | CN102872212A Screening method of liver X receptor agonist |
| 01/16/2013 | CN102872209A Fumaiding medicine extractive composition and preparation method and application thereof |
| 01/16/2013 | CN102872203A Technology for synchronously producing total flavone, total alkaloid and total polysaccharide in mulberry bark |
| 01/16/2013 | CN102872194A Traditional Chinese medicine decoction for treating ischemic cardiovascular and cerebrovascular diseases |
| 01/16/2013 | CN102872191A Channel dredging thrombolytic capsules and making technology |
| 01/16/2013 | CN102872188A Orally-taken medicine for treating haemorrhoids and preparation method thereof |
| 01/16/2013 | CN102872185A Method for ultrasonically extracting coumarin from alfalfa |
| 01/16/2013 | CN102872175A Ligusticum chuanxiong hort extract and preparation method and application thereof |
| 01/16/2013 | CN102872168A Preparation method of ilicin A and total triterpenoids contained in Hainan holly leaf and application of ilicin A and total triterpenoids |
| 01/16/2013 | CN102872167A Cyanotis root extract rich in beta-ecdysone and preparation method thereof |
| 01/16/2013 | CN102872155A Application of flavonoid glycoside compound on medicine for treating cerebral apoplexy |